Ohne eingeschaltetes JavaScript können Sie PSIAC nicht in vollem Umfang nutzen.
Literaturverzeichnis
Menon RM. Clin Pharmacokinet. Oct 2017; 56(10): 1125-1137
Pubmed [6681]
Menon RM. J Hepatol. Jul 2015; 63(1): 20-9
Pubmed [6942]
Mensa FJ. Future Microbiol. Jan 2019; 14: 89-110
Pubmed [7875]
Menzel K. Curr Drug Metab. Jan 2021; 22(10): 784-794
Pubmed [11964]
Mercadante S. Clin J Pain. Jan 2013; 29(1): 15-9
Pubmed [12959]
Merchant S. Ann Transl Med. Dec 2022; 10(23): 1262
Pubmed [12749]
Merdink JL. Toxicology. Mar 2008; 245(1-2): 130-40
Pubmed [85]
Merello M et al., J Neurol Neurosurg Psychiatry (1994) 57, 186-9 [1317]
Merello M. Clin Neuropharmacol. Sep 1999; 22(5): 273-6
Pubmed [9912]
Mergenthaler J. Naunyn Schmiedebergs Arch Pharmacol. Apr 2001; 363(4): 472-80
Pubmed [9077]
Meridia (Sibutramine). Product Information. Physicians` Desk Reference 2002 [1753]
Merli M. J Antimicrob Chemother. Mar 2017; 72(3): 812-815
Pubmed [6557]
Merlos M. J Pharmacol Exp Ther. Jan 1997; 280(1): 114-21
Pubmed [8770]
Mermelstein AC. J Clin Psychopharmacol. Feb 2016; 36(1): 97-8
Pubmed [9771]
Merry C. AIDS. Feb 1997; 11(2): 268-9
Pubmed [1895]
Merry C. AIDS. Mar 1997; 11(4): F29-33
Pubmed [7330]
Merry C. AIDS. Oct 1999; 13(15): F101-7
Pubmed [6887]
Mertens B. Neuropharmacology. Jun 2010; 58(7): 1038-44
Pubmed [2475]
Mertens-Talcott SU. J Clin Pharmacol. Dec 2006; 46(12): 1390-416
Pubmed [3185]
Mertz D. Am J Kidney Dis. Jul 2009; 54(1): e1-4
Pubmed [6453]
Merz T. Am J Health Syst Pharm. Sep 2007; 64(17): 1818-21
Pubmed [12062]
Mesaros JD. J Am Acad Child Adolesc Psychiatry. Jul 1993; 32(4): 877-8
Pubmed [12443]
Meszaros K. Neuropsychobiology. Jan 1997; 36(2): 69-72
Pubmed [12656]
Métayer I. Ann Dermatol Venereol. Jun 2001; 128(6-7): 729-31
Pubmed [8828]
Methling K. Drug Metab Dispos. Mar 2009; 37(3): 479-93
Pubmed [4632]
Metz DC. Dig Dis Sci. Apr 1995; 40(4): 912-5
Pubmed [7327]
Metzger NL. Int J STD AIDS. Jun 2014; 25(7): 532-4
Pubmed [7983]
Meyer BH. Int J Clin Pharmacol Ther Toxicol. Apr 1992; 30(4): 117-21
Pubmed [1260]
Meyer MR. Toxicol Lett. Oct 2009; 190(1): 54-60
Pubmed [7759]
Meyer T. J Neurol. Apr 2008; 255(4): 587-91
Pubmed [11408]
Meyer-Massetti C. Int J Clin Pharm. Oct 2011; 33(5): 806-14
Pubmed [2237]
Meyers CD. Clin Pharmacol Drug Dev. Nov 2016; 5(6): 450-459
Pubmed [8632]
Meymandi MS. Pharmacol Rep. Jan 2012; 64(3): 576-85
Pubmed [9465]
Micardis (Telmisartan). Boehringer Ingelheim Limited. Summary of product characteristics. December 1999 [1759]
Miceli JJ. Br J Clin Pharmacol. Jan 2000; 49 Suppl 1: 65S-70S
Pubmed , Volltext , DOI [2492]
Miceli JJ. Br J Clin Pharmacol. Jan 2000; 49 Suppl 1: 71S-76S
Pubmed , Volltext , DOI [2496]
Michael Levine, MD Heikki Nikkanen, MD Daniel J. Pallin, MD. The Journal of Emergency Medicine. Feb 2009; 40(1): 41-46
Pubmed [13016]
Michael Paulzen, Georgios Schoretsanitis, Benedikt Stegmann, Christoph Hiemke, Gerhard Gründer, Koen R.J. Schruers, Sebastian Walther, Sarah E. Lammertz, Ekkehard Haen. Progress in Neuro-Psychopharmacology and Biological Psychiatry. Jul 2017; 76: 101-106
Pubmed [13732]
Michaels I. Anesth Analg. Nov 1984; 63(11): 1041-4
Pubmed [13114]
Michalets EL. Ann Pharmacother. Jul 1998; 32(7-8): 761-5
Pubmed [10334]
Michalets EL. Clin Pharmacokinet. Jul 2000; 39(1): 49-75
Pubmed [3977]
Michalopoulou PG. J Clin Psychopharmacol. Oct 2012; 32(5): 719-20
Pubmed [10396]
Michaud V, Turgeon J. Drug Metab Lett. 2010 Apr 1;4(2):69-76 [3084]
Michaud V. Drug Metab Lett. Apr 2010; 4(2): 69-76
Pubmed [1087]
Michaud V. Ther Drug Monit. Dec 2006; 28(6): 779-83
Pubmed [3100]
Michaud, Turgeon. Drug Metab Lett 2010, Apr 1;4(2):69-76 [2594]
Michel MC. Expert Opin Pharmacother. Jan 2004; 5(1): 151-60
Pubmed [13159]
Michels G. Dtsch Med Wochenschr. Jan 2012; 137(4): 131-2
Pubmed [5733]
Michelucci R. Epilepsia. Nov 1996; 37(11): 1107-10
Pubmed [761]
Michielsen PJ. Tijdschr Psychiatr. Jan 2007; 49(9): 655-9
Pubmed [10485]
Mico' U. Int Clin Psychopharmacol. Nov 2011; 26(6): 303-10
Pubmed [10489]
Micov A. Pharmacol Res. Jul 2015; 97: 131-42
Pubmed [9598]
Micuda S. Clin Exp Pharmacol Physiol. Apr 2007; 34(4): 296-303
Pubmed [4495]
Micuda S. Eur J Clin Pharmacol. Oct 2004; 60(8): 583-9
Pubmed [408]
Middle et al. Int J Clin Pharmacol Ther 1995; 33: 304–07 [2157]
Midgley I. Xenobiotica. Jan 1994; 24(1): 79-92
Pubmed [8505]
Midoneck SR. N Engl J Med. Nov 1995; 333(22): 1505
Pubmed [5818]
Miesner AR. Ann Pharmacother. Aug 2016; 50(8): 689-90
Pubmed [7326]
Mifsud EJ. Antiviral Res. Apr 2020; 176: 104751
Pubmed [8568]
Migliardi G. Clin Neuropharmacol. Mar 2007; 30(2): 107-13
Pubmed [2638]
Mignat C. Drug Saf. May 1995; 12(5): 334-47
Pubmed [1718]
Mignot E. Lancet Neurol. Feb 2022; 21(2): 125-139
Pubmed [11782]
Mihara et al. Ther Drug Monit (1997) 19, 43-45 [2381]
Mihara K. Psychopharmacology (Berl). Sep 1997; 133(1): 95-8
Pubmed [10218]
Mijatović V. J Forensic Sci. Sep 2014; 59(5): 1280-5
Pubmed [1267]
Mika J. Pharmacol Rep. Jan 2013; 65(6): 1611-21
Pubmed [12121]
Mikati M et al. Neurology (1990) 40 (Suppl 1), 138 [715]
Mikhail N. Curr Drug Saf. May 2009; 4(2): 121-2
Pubmed [6486]
Mikkaichi T. Drug Metab Dispos. Apr 2014; 42(4): 520-8
Pubmed [4071]
Mikkelsen EJ. Caffeine and schizophrenia. J Clin Psychiatry (1978) 39, 732-5 [853]
Mikus G. Clin Pharmacokinet. Mar 2019
Pubmed [7592]
Mikus G. Clin Pharmacol Ther. Aug 2006; 80(2): 126-35
Pubmed [6424]
Milano G. Clin Psychopharmacol Neurosci. Aug 2017; 15(3): 292-295
Pubmed [11223]
Mildvan D. J Acquir Immune Defic Syndr. Apr 2002; 29(5): 471-7
Pubmed [7130]
Miles FK. Med J Aust. Nov 1999; 171(9): 472-5
Pubmed [11960]
Milic M. Clin Ther. Apr 2006; 28(4): 582-90
Pubmed [13062]
Milinkovic A. Expert Rev Anti Infect Ther. Jun 2004; 2(3): 367-73
Pubmed [7137]
Militaru FC. J Med Life. Apr 2015; 8(2): 171-5
Pubmed , Volltext [9959]
Millan MJ. Psychopharmacology (Berl). Aug 2003; 168(4): 397-409
Pubmed [4095]
Millan MJ. Psychopharmacology (Berl). Feb 2005; 177(4): 448-58
Pubmed [2852]
Millar AB. Genitourin Med. Jun 1990; 66(3): 156-8
Pubmed , Volltext [7280]
Miller AD. Pharmacotherapy. Apr 2011; 31(4): 408-23
Pubmed [7299]
Miller DB. Clin Pharmacokinet. Feb 1998; 34(2): 155-62
Pubmed [276]
Miller DD. Am J Psychiatry. Mar 1983; 140(3): 351-2
Pubmed [13011]
Miller DD. J Clin Psychiatry. Jan 1991; 52(1): 23-5
Pubmed [1182]
Miller DG. J Emerg Med. Jan 2011; 40(1): 25-7
Pubmed [3606]
Miller FA, Rampling D. Adverse effects of combined propanolol and chlorpromazine therapy. Am J Psychiatry (1982) 139, 1189-9 [925]
Miller JL. Am J Health Syst Pharm. Apr 2000; 57(7): 625-6
Pubmed [6888]
Miller KM. Drugs. Feb 2019; 79(3): 291-302
Pubmed [8846]
Miller RG. Cochrane Database Syst Rev. Jan 2002; (2): CD001447
Pubmed [11377]
Miller RR. Chest. Mar 1979; 75(3): 356-8
Pubmed [6793]
Bildrechte: © spinetta / Fotolia